|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.465
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.293
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.272
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.257
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.256
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.221
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.171
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.169
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.157
|
|
|
|
glial cell apoptotic process
|
GO:0034349 |
3 |
0.149
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.147
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.142
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.139
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.138
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.134
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.133
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.132
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.131
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.131
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.129
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.125
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.117
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.116
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.107
|
|
|
|
histone h4 k16 acetylation
|
GO:0043984 |
3 |
0.106
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.100
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.095
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.094
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.094
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.094
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.087
|
Fly |
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.087
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.086
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.083
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.082
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.080
|
Fly |
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.079
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.079
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.076
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.074
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.074
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.073
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.072
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.072
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.072
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.071
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.069
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.069
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.067
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.067
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.067
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.067
|
|
|
|
negative regulation of osteoblast proliferation
|
GO:0033689 |
4 |
0.065
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.065
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.065
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.065
|
|
|
|
release of cytochrome c from mitochondria
|
GO:0001836 |
23 |
0.065
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.064
|
|
|
|
mrna processing
|
GO:0006397 |
63 |
0.063
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.063
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.062
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.062
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.061
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.061
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.061
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.060
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.059
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.058
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.056
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.056
|
|
|
|
double strand break repair
|
GO:0006302 |
48 |
0.055
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.054
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.054
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.053
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.053
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.052
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.052
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.052
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.051
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.051
|
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.051
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.050
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.050
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.050
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.050
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.049
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.049
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.049
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.049
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.049
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.049
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.049
|
|
|
|
vesicle organization
|
GO:0016050 |
60 |
0.049
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.048
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.047
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.044
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.044
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.044
|
|
|
|
negative regulation of cyclin dependent protein serine threonine kinase activity
|
GO:0045736 |
9 |
0.044
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.044
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.044
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.043
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.043
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.041
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.041
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.041
|
|
|
|
mrna catabolic process
|
GO:0006402 |
22 |
0.041
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.041
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.041
|
|
|
|
dna templated transcriptional preinitiation complex assembly
|
GO:0070897 |
4 |
0.041
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.041
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.040
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.040
|
|
|
|
nucleic acid phosphodiester bond hydrolysis
|
GO:0090305 |
49 |
0.039
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.039
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.039
|
|
|
|
positive regulation of thymocyte migration
|
GO:2000412 |
2 |
0.038
|
|
|
|
secretory granule organization
|
GO:0033363 |
20 |
0.038
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.038
|
|
|
|
regulation of interleukin 1 alpha production
|
GO:0032650 |
4 |
0.036
|
|
|
|
tumor necrosis factor ligand superfamily member 11 production
|
GO:0072535 |
1 |
0.036
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.036
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.036
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.035
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.035
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.035
|
|
|
|
positive regulation of interleukin 1 alpha production
|
GO:0032730 |
4 |
0.035
|
|
|
|
signal transduction involved in mitotic dna damage checkpoint
|
GO:1902402 |
3 |
0.035
|
|
|
|
positive regulation of myeloid leukocyte differentiation
|
GO:0002763 |
26 |
0.034
|
|
|
|
signal transduction involved in dna damage checkpoint
|
GO:0072422 |
3 |
0.034
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.034
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.034
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.034
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.034
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.034
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.033
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.033
|
|
|
|
definitive hemopoiesis
|
GO:0060216 |
20 |
0.033
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.033
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.033
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.032
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.032
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.032
|
|
|
|
apoptotic mitochondrial changes
|
GO:0008637 |
48 |
0.032
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.032
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.032
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.032
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.032
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.031
|
|
|
|
negative regulation of dna replication
|
GO:0008156 |
4 |
0.031
|
|
|
|
dna endoreduplication
|
GO:0042023 |
4 |
0.031
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.031
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.031
|
|
|
|
deoxyribonucleoside triphosphate biosynthetic process
|
GO:0009202 |
2 |
0.031
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.031
|
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
48 |
0.031
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.031
|
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.031
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.031
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.031
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.031
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.030
|
|
|
|
dna templated transcription termination
|
GO:0006353 |
4 |
0.030
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.030
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.030
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.030
|
|
|
|
regulation of transcription involved in g1 s transition of mitotic cell cycle
|
GO:0000083 |
3 |
0.030
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.030
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.030
|
Fly |
|
|
regulation of chromatin silencing
|
GO:0031935 |
2 |
0.029
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.029
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.029
|
|
|
|
dna replication
|
GO:0006260 |
52 |
0.029
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.029
|
|
|
|
regulation of apoptotic dna fragmentation
|
GO:1902510 |
5 |
0.029
|
|
|
|
cellular response to topologically incorrect protein
|
GO:0035967 |
25 |
0.029
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.029
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.029
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.029
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.029
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.029
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.029
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.029
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.029
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.028
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.028
|
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.028
|
|
|
|
signal transduction involved in dna integrity checkpoint
|
GO:0072401 |
3 |
0.028
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.028
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.028
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.028
|
|
|
|
positive regulation of defense response to bacterium
|
GO:1900426 |
1 |
0.028
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.028
|
|
|
|
rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0051123 |
3 |
0.027
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.027
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.027
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.027
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.027
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.027
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.027
|
|
|
|
protein deacetylation
|
GO:0006476 |
32 |
0.027
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.027
|
|
|
|
activation of cysteine type endopeptidase activity
|
GO:0097202 |
27 |
0.027
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.026
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.026
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.025
|
|
|
|
rna catabolic process
|
GO:0006401 |
29 |
0.025
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.025
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.025
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.025
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.025
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.025
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.025
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
49 |
0.025
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.024
|
|
|
|
dna integrity checkpoint
|
GO:0031570 |
28 |
0.024
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.024
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.024
|
|
|
|
positive regulation of myeloid cell differentiation
|
GO:0045639 |
43 |
0.024
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.024
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.024
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.024
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.024
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.024
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.024
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.024
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.023
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
39 |
0.023
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.023
|
|
|
|
regulation of proteasomal protein catabolic process
|
GO:0061136 |
46 |
0.023
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.023
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.023
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.023
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.023
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.023
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.023
|
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.023
|
|
|
|
apoptotic nuclear changes
|
GO:0030262 |
9 |
0.023
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.023
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.023
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.023
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.022
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.022
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.022
|
|
|
|
positive regulation of transcription elongation from rna polymerase ii promoter
|
GO:0032968 |
2 |
0.022
|
|
|
|
protein polyubiquitination
|
GO:0000209 |
33 |
0.022
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.022
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.022
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.022
|
|
|
|
cellular component disassembly involved in execution phase of apoptosis
|
GO:0006921 |
9 |
0.022
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
57 |
0.022
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.022
|
|
|
|
transcription initiation from rna polymerase ii promoter
|
GO:0006367 |
8 |
0.021
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.021
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
43 |
0.021
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.021
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.021
|
|
|
|
regulation of interleukin 1 alpha secretion
|
GO:0050705 |
3 |
0.021
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.021
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.021
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.021
|
|
|
|
zymogen activation
|
GO:0031638 |
41 |
0.021
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.021
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.021
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
36 |
0.021
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.021
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.021
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.021
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.021
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.021
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.020
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.020
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.020
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.020
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.020
|
|
|
|
prevention of polyspermy
|
GO:0060468 |
4 |
0.020
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.020
|
|
|
|
memory
|
GO:0007613 |
58 |
0.020
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.020
|
|
|
|
transcription from rna polymerase i promoter
|
GO:0006360 |
13 |
0.020
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.020
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.020
|
|
|
|
activation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0006919 |
27 |
0.019
|
|
|
|
regulation of execution phase of apoptosis
|
GO:1900117 |
9 |
0.019
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.019
|
|
|
|
execution phase of apoptosis
|
GO:0097194 |
19 |
0.019
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.019
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.019
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.019
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.019
|
|
|
|
signal transduction involved in mitotic cell cycle checkpoint
|
GO:0072413 |
3 |
0.019
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.019
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.019
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.019
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.019
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.019
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.019
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.019
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.019
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.019
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.019
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.019
|
|
|
|
interleukin 1 alpha secretion
|
GO:0050703 |
3 |
0.019
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.019
|
|
|
|
dna damage checkpoint
|
GO:0000077 |
26 |
0.019
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.019
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.019
|
|
|
|
positive regulation of chromatin modification
|
GO:1903310 |
28 |
0.019
|
|
|
|
peptidyl lysine trimethylation
|
GO:0018023 |
12 |
0.018
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.018
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.018
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.018
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.018
|
|
|
|
response to granulocyte macrophage colony stimulating factor
|
GO:0097012 |
3 |
0.018
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.018
|
|
|
|
signal transduction involved in cell cycle checkpoint
|
GO:0072395 |
3 |
0.018
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.018
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.018
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.018
|
|
|
|
cellular response to gamma radiation
|
GO:0071480 |
4 |
0.018
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.018
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.018
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.018
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.018
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.018
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.018
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.018
|
|
|
|
response to endoplasmic reticulum stress
|
GO:0034976 |
53 |
0.018
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.017
|
|
|
|
signal transduction involved in mitotic dna integrity checkpoint
|
GO:1902403 |
3 |
0.017
|
|
|
|
thymocyte apoptotic process
|
GO:0070242 |
19 |
0.017
|
|
|
|
rna splicing via transesterification reactions
|
GO:0000375 |
43 |
0.017
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.017
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.017
|
|
|
|
chromatin silencing at rdna
|
GO:0000183 |
3 |
0.017
|
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
38 |
0.017
|
|
|
|
mrna splicing via spliceosome
|
GO:0000398 |
43 |
0.017
|
|
|
|
cilium assembly
|
GO:0042384 |
81 |
0.017
|
|
|
|
peptidyl lysine methylation
|
GO:0018022 |
29 |
0.017
|
|
|
|
positive regulation of tor signaling
|
GO:0032008 |
3 |
0.017
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.017
|
|
|
|
regulation of insulin receptor signaling pathway
|
GO:0046626 |
21 |
0.017
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.017
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.017
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.017
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.017
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.016
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.016
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.016
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.016
|
|
|
|
mitotic g1 dna damage checkpoint
|
GO:0031571 |
4 |
0.016
|
|
|
|
dna damage response signal transduction by p53 class mediator resulting in cell cycle arrest
|
GO:0006977 |
3 |
0.016
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.016
|
|
|
|
liposaccharide metabolic process
|
GO:1903509 |
27 |
0.016
|
|
|
|
cilium morphogenesis
|
GO:0060271 |
102 |
0.016
|
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.016
|
|
|
|
regulation of alpha beta t cell differentiation
|
GO:0046637 |
35 |
0.016
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.016
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.016
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.016
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.016
|
|
|
|
positive regulation of synaptic growth at neuromuscular junction
|
GO:0045887 |
1 |
0.016
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.016
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.016
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.016
|
|
|
|
dna templated transcription initiation
|
GO:0006352 |
13 |
0.016
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.016
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.016
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.015
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.015
|
|
|
|
regulation of mrna processing
|
GO:0050684 |
41 |
0.015
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.015
|
|
|
|
regulation of histone h3 k4 methylation
|
GO:0051569 |
12 |
0.015
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.015
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.015
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.015
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.015
|
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.015
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.015
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.015
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.015
|
|
|
|
regulation of defense response to bacterium
|
GO:1900424 |
3 |
0.015
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.015
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.015
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.015
|
|
|
|
positive regulation of nf kappab transcription factor activity
|
GO:0051092 |
30 |
0.015
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.015
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.015
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.015
|
|
|
|
regulation of mrna metabolic process
|
GO:1903311 |
43 |
0.015
|
|
|
|
rna splicing
|
GO:0008380 |
54 |
0.015
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic signaling pathway
|
GO:2001267 |
4 |
0.015
|
|
|
|
extracellular matrix dependent thymocyte migration
|
GO:0072680 |
1 |
0.015
|
|
|
|
regulation of lymphocyte apoptotic process
|
GO:0070228 |
41 |
0.015
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.015
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.014
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.014
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.014
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.014
|
|
|
|
histone deacetylation
|
GO:0016575 |
26 |
0.014
|
|
|
|
viral gene expression
|
GO:0019080 |
3 |
0.014
|
|
|
|
localization within membrane
|
GO:0051668 |
4 |
0.014
|
|
|
|
regulation of nuclear cell cycle dna replication
|
GO:0033262 |
2 |
0.014
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.014
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.014
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.014
|
|
|
|
intracellular signal transduction involved in g1 dna damage checkpoint
|
GO:1902400 |
3 |
0.014
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
49 |
0.014
|
|
|
|
negative regulation of protein depolymerization
|
GO:1901880 |
21 |
0.014
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.014
|
|
|
|
t cell differentiation involved in immune response
|
GO:0002292 |
30 |
0.014
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.014
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.014
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.014
|
Fly |
|
|
t cell apoptotic process
|
GO:0070231 |
39 |
0.014
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.014
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.014
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.014
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.014
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.014
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.014
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.014
|
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.014
|
|
|
|
hepatocyte apoptotic process
|
GO:0097284 |
11 |
0.014
|
|
|
|
chromatin remodeling
|
GO:0006338 |
32 |
0.014
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.014
|
|
|
|
macrophage differentiation
|
GO:0030225 |
20 |
0.014
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.014
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.014
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.014
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.014
|
|
|
|
b cell proliferation
|
GO:0042100 |
53 |
0.014
|
|
|
|
fibronectin dependent thymocyte migration
|
GO:0072681 |
1 |
0.014
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.014
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.014
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.013
|
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.013
|
|
|
|
regulation of thymocyte apoptotic process
|
GO:0070243 |
14 |
0.013
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.013
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.013
|
|
|
|
positive regulation of histone modification
|
GO:0031058 |
28 |
0.013
|
|
|
|
response to topologically incorrect protein
|
GO:0035966 |
25 |
0.013
|
|
|
|
microtubule cytoskeleton organization involved in mitosis
|
GO:1902850 |
4 |
0.013
|
|
|
|
natural killer cell proliferation
|
GO:0001787 |
3 |
0.013
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.013
|
|
|
|
positive regulation of dna templated transcription elongation
|
GO:0032786 |
2 |
0.013
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.013
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.013
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.013
|
|
|
|
negative regulation of b cell activation
|
GO:0050869 |
27 |
0.013
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.013
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.013
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.013
|
|
|
|
er nucleus signaling pathway
|
GO:0006984 |
27 |
0.013
|
|
|
|
glycolipid metabolic process
|
GO:0006664 |
25 |
0.013
|
|
|
|
protein depolymerization
|
GO:0051261 |
34 |
0.013
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.013
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.013
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.013
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.013
|
|
|
|
t cell homeostasis
|
GO:0043029 |
35 |
0.013
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.013
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.013
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.013
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.013
|
|
|
|
positive regulation of protein oligomerization
|
GO:0032461 |
4 |
0.013
|
|
|
|
positive regulation of antibacterial peptide biosynthetic process
|
GO:0006963 |
1 |
0.012
|
|
|
|
histone h4 k20 methylation
|
GO:0034770 |
8 |
0.012
|
|
|
|
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002824 |
61 |
0.012
|
|
|
|
cytokine metabolic process
|
GO:0042107 |
71 |
0.012
|
|
|
|
regulation of transcription during meiosis
|
GO:0051037 |
1 |
0.012
|
|
|
|
cell cell recognition
|
GO:0009988 |
44 |
0.012
|
|
|
|
transdifferentiation
|
GO:0060290 |
1 |
0.012
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.012
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.012
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.012
|
|
|
|
megakaryocyte differentiation
|
GO:0030219 |
26 |
0.012
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.012
|
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.012
|
|
|
|
nucleus organization
|
GO:0006997 |
45 |
0.012
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.012
|
|
|
|
dna catabolic process endonucleolytic
|
GO:0000737 |
15 |
0.012
|
|
|
|
negative regulation of b cell proliferation
|
GO:0030889 |
13 |
0.012
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.012
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.012
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.012
|
|
|
|
histone h3 k4 trimethylation
|
GO:0080182 |
5 |
0.012
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.012
|
|
